| Dr William Elliot Rosenfeld, MD | |
|
222 S Woods Mill Rd, Suite 610n, Chesterfield, MO 63017-3625 | |
| (314) 453-9300 | |
| Not Available |
| Full Name | Dr William Elliot Rosenfeld |
|---|---|
| Gender | Male |
| Speciality | Psychiatry & Neurology - Neurology |
| Location | 222 S Woods Mill Rd, Chesterfield, Missouri |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1851413587 | NPI | - | NPPES |
| 202431011 | Medicaid | MO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084N0400X | Psychiatry & Neurology - Neurology | MDR9G50 (Missouri) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr William Elliot Rosenfeld, MD 222 S Woods Mill Rd Ste 610n, Chesterfield, MO 63017-3647 Ph: (314) 453-9300 | Dr William Elliot Rosenfeld, MD 222 S Woods Mill Rd, Suite 610n, Chesterfield, MO 63017-3625 Ph: (314) 453-9300 |
News Archive
ProFibrix B.V., a leader in the development of innovative products for hemostasis and regenerative medicine, today announced that SenterNovem, an agency of the Dutch Ministry of Economic Affairs, has granted the company a loan under its new Innovation Credit scheme of potentially up to EUR 5 million to finance the further clinical development of its unique new hemostat Fibrocaps(TM).
Few novel or emerging infectious diseases have posed such vital ethical challenges so quickly and dramatically as the novel coronavirus.
Lazarus Effect, a medical device company focused on the development of novel interventional devices to facilitate removal of blood clots, announced the closing of a $5 million financing. Proceeds from the financing will support EU commercialization of several approved Lazarus Effect devices, as well as regulatory filings for the Lazarus ReCover and Lazarus Cover in the United States.
Treatment with the class of chemotherapy drugs called anthracyclines improves survival in women with HER2-positive breast cancer who have previously had surgery, but it may not offer any benefit for women with HER2-negative tumors, according to a study published online December 25 in the Journal of the National Cancer Institute.
› Verified 4 days ago
Amy C Rauchway, D.O. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1176 Town And Country Commons, Chesterfield, MO 63017 Phone: 636-893-1260 Fax: 636-893-1261 | |
Dr. Frasat Chaudhry, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 232 S Woods Mill Rd, 400 East, Chesterfield, MO 63017 Phone: 314-878-2888 Fax: 314-576-8167 | |
Dr. Todd Brook Silverman, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 14825 North Outer 40 Rd Ste 330-b, Chesterfield, MO 63017 Phone: 636-537-0525 Fax: 636-537-0575 | |
Dr. Beth Ann Ward, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 232 S Woods Mill Rd, Sleep Medicine, Chesterfield, MO 63017 Phone: 314-205-6030 Fax: 314-338-7157 | |
Katherine P. Buchowski, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 15455 Conway Rd Ste 117, Chesterfield, MO 63017 Phone: 314-388-9855 Fax: 314-470-6997 | |
Patti M Nemeth, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 232 S Woods Mill Rd, Suite 400 East, Chesterfield, MO 63017 Phone: 314-878-2888 Fax: 314-576-8167 | |
Savita S. Bhat, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 167 Lamp And Lantern Vlg Ste 292, Chesterfield, MO 63017 Phone: 314-736-5575 Fax: 314-736-5576 |